Impact of PCSK9, WDR12, CDKN2A, and CXCL12 Polymorphisms in Jordanian Cardiovascular Patients on Warfarin Responsiveness and Sensitivity
Rasheed K Ibdah,1 Laith N AL-Eitan,2 Nasr N Alrabadi,3 Ayah Y Almasri,2 Adan H Alnaamneh,2 Rame H Khasawneh,4 Mansour A Alghamdi5,6 1Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan; 2Department of Biotechnology...
Main Authors: | Ibdah RK, AL-Eitan LN, Alrabadi NN, Almasri AY, Alnaamneh AH, Khasawneh RH, Alghamdi MA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-01-01
|
Series: | International Journal of General Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/impact-of-pcsk9-wdr12-cdkn2a-and-cxcl12-polymorphisms-in-jordanian-car-peer-reviewed-article-IJGM |
Similar Items
-
Influence of PSRC1, CELSR2, and SORT1 Gene Polymorphisms on the Variability of Warfarin Dosage and Susceptibility to Cardiovascular Disease
by: AL-Eitan LN, et al.
Published: (2020-11-01) -
Deficiency of Wdr60 and Wdr34 cause distinct neural tube malformation phenotypes in early embryos
by: Lu Yan, et al.
Published: (2023-05-01) -
Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors
by: Refaat A. Eid, et al.
Published: (2023-01-01) -
Expression of cyclin-dependent kinase inhibitors (CDKN1, CDKN5) in developmentally competent and incompetent porcine oocytes
by: H. Piotrowska, et al.
Published: (2013-09-01) -
Targeting MYC through WDR5
by: Lance R. Thomas, et al.
Published: (2020-03-01)